Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
Exane BNP Paribas analyst Victor Floch upgraded Genmab (GMAB) to Neutral from Underperform with a DKK 1,500 price target. The shares trade at a ...
Fintel on MSN4d
Exane BNP Paribas Upgrades Array Technologies (ARRY)
Fintel reports that on February 6, 2025, Exane BNP Paribas upgraded their outlook for Array Technologies (NasdaqGM:ARRY) from ...
Genmab stock rating raised, price target cut by BNP Paribas Exane
Exane analyst Victor Floch upgraded Genmab (NASDAQ:GMAB) A/S shares from Underperform to Neutral, adjusting the price target ...
Robert Half upgraded to Outperform from Underperform at Exane BNP Paribas
Exane BNP Paribas analyst Andrew Grobler upgraded Robert Half (RHI) to Outperform from Underperform with a $71.50 price target Maximize Your ...
Nasdaq14d
Exane BNP Paribas Upgrades Array Technologies (ARRY)
Fintel reports that on February 6, 2025, Exane BNP Paribas upgraded their outlook for Array Technologies (NasdaqGM:ARRY) from Underperform to Neutral. As of January 29, 2025, the average one-year ...
FIIs still hold $800 bn in Indian equities, but continued selling poses risk: Report
Foreign institutional investors (FIIs) continue to hold approximately USD 800 billion worth of Indian equities, but their ...
devdiscourse1d
Foreign Investors Shape Indian Market Amid Challenges
Foreign institutional investors hold significant Indian equities, posing market risks. Domestic investments grow as a ...
Investing5d
BNP Paribas Exane cuts WEIR Group stock rating to neutral
On Thursday, BNP Paribas (OTC:BNPQY) Exane analyst Bruno Gjani downgraded WEIR Group Plc. (WEIR:LN) (OTC: WEGRY (OTC:WEGRY)) stock rating from Outperform to Neutral, setting a price target of ...
Foreign investors still hold USD 800 bn in Indian equities, but continued selling poses risk: Report
Foreign institutional investors (FIIs) continue to hold approximately USD 800 billion worth of Indian equities, but their ...